AstraZeneca resumes US vaccine trial

By Julie Steenhuysen and Carl O'Donnell
Updated October 24 2020 - 8:36am, first published 8:31am
The US trial of AstroZeneca's experimental vaccine for Covid-19 has resumed, after a safety check.
The US trial of AstroZeneca's experimental vaccine for Covid-19 has resumed, after a safety check.

AstraZeneca Plc has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial as early as next week, the companies said on Friday.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Singleton news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.